Previous 10 | Next 10 |
- Initiation of Phase 2b ODYSSEY Trial of CLS-AX in Wet AMD Expected in Q2 2023 - - Medical Meeting Presentations Highlight Significant Potential of CLS-AX Based on Positive OASIS Phase 1/2a Safety Data, Durability, and Biologic Effect Over 6 Months - - Continued...
2023-03-06 10:31:11 ET Summary The Cornerstone funds (CLM) and (CRF) tend to trade at some of the highest market price premiums of all CEFs, generally from +10% to as high as +60% historically. The reasons for the premium valuations have to do with their incredibly high market yie...
Summary Cornerstone Total Return Fund has been a contentious fund to discuss. The fund has a huge following for its generous payouts. We discuss how this remains one of the final signposts of the ZIRP bubble and how we think this ends within a year. Cornerstone Total Retur...
ALPHARETTA, Ga., Feb. 23, 2023 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS ® ), announced today that its fourth quarter and full year...
- CLS-AX OASIS Results Show Favorable Safety Data, Durability and Biologic Effect Over 6 Months in Treatment-Experienced Anti-VEGF Sub-Responders - - SCS Microinjector ® Featured in Favorable Data Presentations Related to Multiple Therapies in Clinical Development ...
Summary 17 out of 22 CEF sectors positive on price and 18 out of 22 sectors positive on NAV last week. RSF offering results. DEX tender offer expires. A new corporate actions tracker for our members. Author’s note: This article was released to CEF/ETF Income Labor...
Cornerstone Strategic Value Fund ( NYSE: CLM ) declares $0.1228/share monthly dividend , in line with previous. Forward yield 17.8% Payable April 28; for shareholders of record April 14; ex-div April 13. Payable May 31; for shareholders of record May 15; ex-div May 12....
Summary It was back in November of 2012, yes, over a decade ago, that I wrote my first article discussing the benefits of high Return of Capital (ROC) in equity CEF distributions. Back then, I first wrote (link below) about the risks and tax-differences between high ROC in equity based ...
ALPHARETTA, Ga, Feb. 07, 2023 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS ® ), announced today that data from the Company’s OAS...
ALPHARETTA, Ga., Feb. 06, 2023 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS ® ), today announced that its Chief Medical Officer and Chi...
News, Short Squeeze, Breakout and More Instantly...
Cornerstone Strategic Value Fund Inc. Company Name:
CLM Stock Symbol:
NYSE Market:
ALPHARETTA, Ga., July 22, 2024 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS ® ), has opened registration for its virtual key opinion l...
ALPHARETTA, Ga., July 11, 2024 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS ® ), announced today the appointment of Glenn C. Yiu, M.D....
- Webinar to be held on Wednesday, July 24, 2024 at 8:00 am ET - - Retina Specialists to Provide Insights and Real-World Experience with Suprachoroidal Drug Delivery - - Target Profile for CLS-AX in Wet AMD Landscape and Potential Opportunities for Clearside Pipeline Expansion - ...